title: Prognostic value of insulin- like growth factor-I receptor expression in renal cell carcinoma.
abstract: The insulin-like growth factor-I receptor (IGF-IR), a tyrosine kinase receptor over expressed in many tumor cell lines and in some human tumors, plays a critical role in transformation, tumorigenicity and metastasis. The aim of the present study is to investigate the role of IGF-IR expression as a prognostic factor in RCC. This study was conducted in a historical cohort of 82 patients who had RCC treated with radical nephrectomy from 1994 to 2005. Specimens were reevaluated with regard to histological subtype, nuclear grade, stage and IGF-IR expression. The IGF-IR stain was semi-quantitatively evaluated using the Allred score system. Kaplan-Meier analysis demonstrated a significant positive correlation between Fuhrman nuclear grade and IGF-IR Allred score (P< 0.0001). Survival in patients with score IGF-I < or = 4 was 90.21 month and in patients with score IGF-1R> 4 was 33.39 month (P Value < 0.0001). Cox regression analysis indicated that expression of IGF-IR is a prognostic factor in patients with RCC (P Value < 0.0001, odds Ratio = 2.38). In conclusion, a statistically significant correlation was demonstrated between IGF-IR expression and Fuhrman nuclear grading and survival in patients with RCC. In stage-by-stage and grade-by-grade analysis; however, it seems that we cannot consider IGF-IR as an independent prognostic factor.
authors.affiliation: Department of Pathology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
authors.forename: Mehrdad Mohammadi
authors.initials: MM
authors.lastname: Sichani
authors.forename: Fateme Sarreshtedar
authors.initials: FS
authors.lastname: Yazdi
authors.forename: Noushin Afshar
authors.initials: NA
authors.lastname: Moghaddam
authors.forename: Ali
authors.initials: A
authors.lastname: Chehrei
authors.forename: Mahmud
authors.initials: M
authors.lastname: Kabiri
authors.forename: Amin
authors.initials: A
authors.lastname: Naeimi
authors.forename: Diana
authors.initials: D
authors.lastname: Taheri
mesh_terms: D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000032:analysis*; D002292:Carcinoma, Renal Cell / Q000737:chemistry* / Q000401:mortality / Q000473:pathology / Q000601:surgery; D016009:Chi-Square Distribution; D015331:Cohort Studies; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D053208:Kaplan-Meier Estimate; D007680:Kidney Neoplasms / Q000737:chemistry* / Q000401:mortality / Q000473:pathology / Q000601:surgery; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D009392:Nephrectomy; D016017:Odds Ratio; D011237:Predictive Value of Tests; D016016:Proportional Hazards Models; D017526:Receptor, IGF Type 1 / Q000032:analysis*; D018570:Risk Assessment; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D014408:Biomarkers, Tumor; D017526:Receptor, IGF Type 1